Bandhan Healthcare Fund Direct Growth NAV today
AMFI: 153972ISIN: INF194KB1KF5MUTF_IN: BAND_HEAL_DIR_CP4DWWBandhan Mutual FundSectoral / Thematic funds
NAV ₹10.7210up ₹0.17 (1.61%)
NAV for 27 Oct 2026, against 26 Oct 2026. Declared once a day.
Other plans: Regular IDCW ₹10.5650 · Regular Growth ₹10.5650, 1.62% · Direct IDCW ₹10.7210
- Fund sizeAssets under management. The money the fund manages for all its investors, across every plan, at the end of the month. Assets under management in the glossary
- ₹333 CrSep 2026
- Expense ratioTotal expense ratio. What the fund charges each year as a share of the money invested, taken out of the NAV every day, so the returns shown are already after it. Total expense ratio: how it is worked out
- 1.25%22 Oct 2026
- Exit loadExit load. A charge, as a share of the amount redeemed, on units sold before a set period has passed since they were bought. Exit load in the glossary
- 0.50%if sold within 30 days
- P/EP/E. What the fund pays for each rupee of yearly profit its companies earn: the total value of its shares divided by those companies' last four quarters of profit, each in proportion to what the fund holds. The profit leaves out one-off items (exceptional items and businesses sold or demerged), so one company's one-off gain cannot pull the fund's P/E down. A loss-making company lowers the profit. Shown when at least 80% of the fund's shares are counted. P/E in the glossary
- 35.930 Sep 2026
- Risk levelRiskometer. The fund's own risk label on SEBI's six-step scale, from Low to Very High, set from what the fund holds and reviewed every month. Riskometer in the glossary
- Very HighAug 2026
- HoldingsHoldings. The number of different securities in the fund's latest monthly portfolio: shares, bonds, money market paper and units of other funds, not cash, overnight lending or futures. Holdings in the glossary
- 3530 Sep 2026
- LaunchedLaunch date. The day the fund first allotted units to investors, at the close of its new fund offer. Launch date in the glossary
- 30 Nov 2025
Bandhan Healthcare Fund returns
Direct Growth plan
Over each window to 27 Oct 2026
| Over | Direct GrowthTrailing return. The change in NAV from the start date to the latest NAV; over a year and longer, the yearly rate that would compound to the same change (CAGR). Trailing return: how it is worked out | Regular Growth | Rank in categoryRank in category. The fund's place among the funds of its category with a return over the same window, highest return first. Rank in category in the glossary | Category medianCategory median. The middle return of the funds in the category over the same window: half returned more, half less. Category median in the glossary | Middle halfMiddle half of the category. The returns of the fund a quarter of the way down the category and the fund a quarter of the way up, over the same window: half the category's funds returned between the two. Middle half of the category in the glossary |
|---|---|---|---|---|---|
| 1 week | +1.12% | +1.09% | – | – | – |
| 1 month | −6.42% | −6.54% | 210 of 254 | −4.84% | −5.8% to −3.6% |
| 3 months | −2.97% | −3.34% | 69 of 250 | −5.21% | −7.0% to −2.5% |
| 6 months | +8.83% | +7.99% | 46 of 250 | −1.54% | −5.2% to +5.0% |
| 1 year | Needs a year | – | – | −3.87% | −8.5% to +2.9% |
| 3 years | Needs 3 years | – | – | +13.05% | +9.0% to +18.1% |
| 5 years | Needs 5 years | – | – | +10.74% | +8.3% to +14.9% |
| 10 years | Needs 10 years | – | – | +14.11% | +11.8% to +15.8% |
₹10,000 put in on 2 Dec 2025 is ₹10,766 at the NAV of 27 Oct 2026Growth of ₹10,000. What ₹10,000 put in at the NAV of the first day would be worth at the latest NAV, after the fund's expenses and before tax and any exit load. Growth of ₹10,000 in the glossaryOver a year and longer, a return is the yearly rate. Rank, median and middle half among the Direct plans of Sectoral / Thematic funds, each fund's return to its latest NAV on or before 28 Oct 2026.
Bandhan Healthcare Fund expense ratio and exit load
Per cent of the money invested, a year. Each month shows its last day filed; the parts were redefined from Apr 2026.
- Regular over directDirect and regular plan cost gap. The regular plan's expense ratio less the direct plan's: what buying through a distributor costs each year, since both plans own the same portfolio. Direct and regular plan cost gap in the glossary
- 1.53 ptsA year, on 22 Oct 2026
- Direct, 30-day averageExpense ratio, 30-day average. The total expense ratio averaged over the last 30 days the fund filed it, which evens out the day-to-day moves in brokerage and levies. Expense ratio, 30-day average in the glossary
- 1.27%Over the last 30 days filed
- Regular, 30-day average
- 2.79%Over the last 30 days filed
Total expense ratio, month by month
- Regular plan
- Direct plan
Direct plan highest 1.31%, Sep 2026.Direct plan lowest 0.65%, Dec 2025.
What the expense ratio is made of
| Part | Direct | Regular |
|---|---|---|
| Base expense ratioBase expense ratio. The part of the expense ratio that pays the fund house and the distributor, before brokerage, transaction costs, levies and GST. Base expense ratio in the glossary | 0.78% | 2.10% |
| Brokerage | 0.11% | 0.11% |
| Transaction costs | 0.01% | 0.01% |
| Statutory levies | 0.35% | 0.56% |
Per cent of assets a year, filed for 22 Oct 2026. The parts add up to that day's total.
Exit load, in the fund house's words
• If redeemed/switched out on or within 30 days from the date of allotment: 0.50% of the applicable NAV • If redeemed/switched out after 30 days from date of allotment – Nil
Buying and selling
- Lump-sum purchases
- Accepted
- Minimum investmentMinimum investment. The smallest amount the plan accepts for a first purchase. Minimum investment in the glossary
- ₹1,000
- Minimum top-up
- ₹1,000
- Minimum redemption
- ₹500
- SIP
- Accepted
- SIP minimum
- ₹100
- SIP instalments, at least
- 6
- STP, transfers to another fund
- Not accepted
- SWP, regular withdrawals
- Accepted
- Switches
- Accepted
- Lock-inLock-in. The time after each purchase during which those units cannot be sold. Lock-in in the glossary
- None
- SIP dates
- Monthly - Investor may choose any day of the month from 1st to 31st as the date of the instalment and Quarterly -Investor may choose any day of the month from 1st to 31st as the date of the instalment
As listed for this plan on 28 Oct 2026.
How Bandhan Healthcare Fund is taxed
Taxed as an equity fund where it keeps 65% or more in shares of listed Indian companies: gains on units held over 12 months are taxed at 12.5% above ₹1.25 lakh a year, and gains on units held 12 months or less at 20%. Otherwise, gains on units held over 24 months are taxed at 12.5%, and gains on units held 24 months or less at the income tax slab rate.
IDCW payouts are added to the holder's income and taxed at the income tax slab rate. The fund deducts 10% tax at source for a resident when its payouts to them in a year counted from April to March are above ₹10,000.
Rules in force from 1 Apr 2025, checked 27 Oct 2026. Surcharge and cess are not included.
Bandhan Healthcare Fund AUM
₹ crore, every plan of the fund together.
- Average assetsAverage assets under management. The money the fund managed, averaged over every day of the quarter, added up across its plans.
- ₹325 CrQuarter to Sep 2026
- In the direct plansShare of assets in the direct plans. The direct plans' average assets for the quarter as a percentage of the fund's total; the rest is in the regular plans, bought through distributors. Share of assets in the direct plans in the glossary
- 5.9%Of the quarter's average
Average assets by quarter, by plan
- Regular plans
- Direct plans
The latest quarter is the largest since the quarter to Dec 2025.
Assets at each month end
The latest month end is the highest since Jul 2026.Lowest ₹319 Cr, Jul 2026.
Bandhan Healthcare Fund portfolio
Portfolio disclosed for 30 Sep 2026.
Holdings on 30 Sep 2026
| Large, mid and small cap. Companies ranked by average market value over six months: the first 100 are large cap, the next 150 mid cap, the rest small cap, by the list in force for the portfolio's month. Large, mid and small cap in the glossary | Weight in the fund. The holding's market value on the portfolio date as a share of the fund's net assets. Weight in the fund in the glossary | Held since. The first month end of the fund's current run of holding this position; marked "or earlier" where that month is the fund's first portfolio on record or the first after a gap in its portfolios. Held since in the glossary | |||
|---|---|---|---|---|---|
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | Large cap13th | 9.74% | 31.79 | 1,75,000 | Nov 2025or earlier |
| CiplaPharmaceuticals & Biotechnology | Large cap99th | 6.18% | 20.19 | 1,50,000 | Nov 2025or earlier |
| Apollo Hospitals EnterpriseHealthcare Services | Large cap97th | 5.75% | 18.78 | 23,000 | Nov 2025or earlier |
| Max Healthcare InstituteHealthcare Services | Mid cap111th | 5.27% | 17.20 | 1,85,000 | Nov 2025or earlier |
| LupinPharmaceuticals & Biotechnology | Mid cap105th | 4.35% | 14.21 | 70,000 | Dec 2025 |
| Divi's LaboratoriesPharmaceuticals & Biotechnology | Large cap50th | 4.27% | 13.94 | 15,000 | Nov 2025or earlier |
| Shilpa MedicarePharmaceuticals & Biotechnology | Small cap637th | 4.17% | 13.61 | 1,30,000 | Dec 2025 |
| Aurobindo PharmaPharmaceuticals & Biotechnology | Mid cap138th | 4.10% | 13.38 | 80,000 | Nov 2025or earlier |
| Dr. Reddy's LaboratoriesPharmaceuticals & Biotechnology | Mid cap104th | 3.78% | 12.33 | 1,00,000 | Nov 2025or earlier |
| GlaxoSmithKline PharmaceuticalsPharmaceuticals & Biotechnology | Mid cap221st | 3.39% | 11.08 | 40,000 | Nov 2025or earlier |
| Torrent PharmaceuticalsPharmaceuticals & Biotechnology | Large cap61st | 3.23% | 10.56 | 22,000 | Jul 2026 |
| Gland PharmaPharmaceuticals & Biotechnology | Small cap261st | 3.11% | 10.15 | 35,000 | Aug 2026 |
| Zydus LifesciencesPharmaceuticals & Biotechnology | Mid cap114th | 2.82% | 9.22 | 79,327 | May 2026 |
| Narayana HrudayalayaHealthcare Services | Mid cap235th | 2.74% | 8.96 | 50,000 | May 2026 |
| Syngene InternationalHealthcare Services | Small cap359th | 2.46% | 8.04 | 2,20,000 | Nov 2025or earlier |
Weight is per cent of the fund's net assets; value in ₹ crore.
Cash and receivables on 30 Sep 2026
| Triparty Repo TRP_011026 | 6.72% | 21.96 |
| Net Current Assets | −0.31% | −1.02 |
| Cash Margin - CCIL | 0.04% | 0.14 |
Weight is per cent of the fund's net assets; value in ₹ crore.
- Largest holdingLargest holding. The share of the fund in its single largest position, cash and futures not counted as positions. Largest holding in the glossary
- 9.74%Sun Pharmaceutical Industries
- Top 5 holdingsTop 5 holdings. The share of the fund held in its five largest positions. Top 5 holdings in the glossary
- 31.29%
- Top 10 holdingsTop 10 holdings. The share of the fund held in its ten largest positions. Top 10 holdings in the glossary
- 51.00%
- Effective holdingsEffective number of holdings. The number of equal-sized positions that would be as concentrated as the fund's actual weights. Effective number of holdings in the glossary
- 23.3Taken over 93.55% of the fund
Asset allocation
Asset allocation. What the fund owns, by kind of asset, each as a share of its net assets; futures and options are shown beside it, not in it, since they are contracts rather than assets bought. Asset allocation in the glossary- Indian shares93.55%
- Cash and receivables6.45%
Per cent of the fund's net assets.
Large, mid and small cap
- Large cap31.18%Category 49.50%
- Mid cap33.45%Category 21.62%
- Small cap35.37%Category 26.68%
Per cent of the fund's Indian shares. By the list for the six months to Jun 2026. Category is the average of 249 Sectoral / Thematic funds.
Sector allocation
Sector weight. The fund's shares grouped by the business each company is in, less the futures sold on them, each group as a share of the fund's net assets. Sector weight in the glossary2sectors
- Healthcare92.72%Category 12.70%
- Financial Services0.83%Category 21.68%
Per cent of the fund's net assets, less the futures sold on its shares, Sep 2026. Category is the average of 254 Sectoral / Thematic funds. Category average. The sector's weight, less the futures sold on it, averaged over the 254 Sectoral / Thematic funds that disclosed a portfolio for Sep 2026. A fund holding none of the sector counts as 0.
Sector allocation month by month
| 11 months | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Healthcare34 companies | 92.72% | 95.08% | 95.47% | 93.97% | 93.59% | 93.20% | 95.01% | 95.56% | 92.61% | 92.00% | 73.81% | |
| Financial Services1 company | 0.83% | 0.89% | 1.01% | 2.48% | 2.43% | 2.40% | 2.21% | 2.27% | 2.48% | 2.46% | 0.00% | |
| Capital Goods | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Automobile And Auto Components | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Consumer Services | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Information Technology | 0.00% | 0.00% | 0.00% | 0.26% | 0.27% | 0.28% | 0.24% | 0.23% | 0.28% | 0.00% | 0.00% | |
| Fast Moving Consumer Goods | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Consumer Durables | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Oil Gas & Consumable Fuels | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Telecommunication | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Power | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Services | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Per cent of the fund's net assets, less the futures sold on its shares, at each month end, Nov 2025 to Sep 2026.
Bought and sold
Sep 2026 against Aug 2026, position by position.
Positions changed, month by month
- New
- Added
- Trimmed
- Sold out
- New positionsNew positions. Holdings in this month's portfolio that were not in the month before. New positions in the glossary
- 0
- Sold outSold out. Holdings in last month's portfolio that are gone from this one, other than a bond or deposit repaid on its due date. Sold out in the glossary
- 0
- Added toAdded to. Holdings with more units than the month before. Where the fund states no units, a weight that rose by more than a tenth. Added to in the glossary
- 6
- TrimmedTrimmed. Holdings with fewer units than the month before. Where the fund states no units, a weight that fell by more than a tenth. Trimmed in the glossary
- 5
- UnchangedUnchanged. Holdings with the same number of units as the month before. Their weight can still move with the price. Unchanged in the glossary
- 24
- Traded at leastTraded at least. The smaller of the weight bought in new positions and the weight sold out of old ones, cash left out: the least the fund must have bought and sold in the month. Traded at least in the glossary
- 0.00%
- Weight that movedWeight that moved. Half the sum of every position's change in weight between the two month ends, new and sold positions included; price moves alone raise it. Weight that moved in the glossary
- 4.77%
Changes in Sep 2026
| What changed. New: not held the month before. Added or trimmed: more or fewer units than the month before, or, where no units are stated, a weight that moved by more than a tenth. Sold out: held the month before, gone now. Matured: a bond or deposit whose repayment date fell between the two portfolios, so it was repaid rather than sold (one sold in its last days reads the same). What changed in the glossary | Change in weight. The holding's weight this month less its weight the month before, in percentage points; a price move alone changes it. Change in weight in the glossary | ||||
|---|---|---|---|---|---|
| Global Health | Trimmed | 1.88% | 2.45% | −0.57 pts | −10,000 |
| Ajanta Pharma | Trimmed | 1.22% | 1.74% | −0.52 pts | −5,000 |
| Lupin | Added | 4.35% | 3.96% | +0.39 pts | +10,000 |
| Healthcare Global Enterprises | Trimmed | 1.33% | 1.66% | −0.33 pts | −10,000 |
| Alivus Life Sciences | Trimmed | 1.15% | 1.36% | −0.21 pts | −5,000 |
| Jubilant Pharmova | Trimmed | 1.26% | 1.46% | −0.20 pts | −15,000 |
| Sai Parenterals | Added | 1.15% | 0.95% | +0.20 pts | +10,000 |
| Narayana Hrudayalaya | Added | 2.74% | 2.59% | +0.15 pts | +5,000 |
| Apollo Hospitals Enterprise | Added | 5.75% | 5.64% | +0.11 pts | +2,000 |
| Rainbow Childrens Medicare | Added | 2.21% | 2.13% | +0.08 pts | +5,000 |
| Syngene International | Added | 2.46% | 2.42% | +0.04 pts | +20,000 |
Weights are per cent of the fund's net assets; a change in weight is in percentage points.
Holdings month by month
| Holding | Oct 25 | Nov 25 | Dec 25 | Jan 26 | Feb 26 | Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 Sun Pharmaceutical Industries | – | 10.05% | 8.68%Cut | 8.56% | 8.84% | 9.65% | 9.34% | 8.68% | 10.11%Added | 10.91% | 10.48% | 9.74% |
 Cipla | – | 6.30% | 6.31%Added | 6.01%Added | 6.86%Added | 6.72% | 6.76% | 6.76% | 6.82% | 6.92% | 6.38% | 6.18% |
 Apollo Hospitals Enterprise | – | 7.55% | 7.82%Added | 8.22% | 8.76% | 8.97% | 8.67% | 8.68% | 8.08%Cut | 8.41% | 5.64%Cut | 5.75%Added |
 Max Healthcare Institute | – | 6.18% | 7.12%Added | 6.93% | 7.50% | 7.14% | 6.92% | 6.29% | 6.30%Cut | 3.44%Cut | 5.81%Added | 5.27% |
 Lupin | – | – | 3.19%Bought | 3.46% | 3.51% | 3.81% | 2.78%Cut | 1.64%Cut | 1.69% | 1.70% | 3.96%Added | 4.35%Added |
 Divi's Laboratories | – | 5.55% | 7.31%Added | 7.36% | 7.39% | 7.40% | 7.61% | 6.43%Cut | 6.12% | 4.04%Cut | 4.28%Cut | 4.27% |
 Shilpa Medicare | – | – | 1.24%Bought | 1.29%Added | 1.43% | 1.60% | 1.75% | 2.41%Added | 2.78% | 2.49%Cut | 3.72% | 4.17% |
 Aurobindo Pharma | – | 1.26% | 2.39%Added | 2.59% | 2.48% | 2.87% | 2.87% | 2.75% | 3.92%Added | 3.96% | 4.14% | 4.10% |
 Dr. Reddy's Laboratories | – | 6.48% | 6.42% | 6.75%Added | 6.77% | 7.12% | 5.92%Cut | 5.03%Cut | 4.21%Cut | 3.59% | 3.48% | 3.78% |
 GlaxoSmithKline Pharmaceuticals | – | 1.76% | 1.66% | 1.89%Added | 1.92% | 1.84% | 1.77% | 1.78%Added | 2.28%Added | 2.49% | 3.68%Added | 3.39% |
 Torrent Pharmaceuticals | – | – | – | – | – | – | – | – | – | 4.50%Bought | 3.36%Cut | 3.23% |
 Gland Pharma | – | – | – | – | – | – | – | – | – | – | 3.05%Bought | 3.11% |
 Zydus Lifesciences | – | – | – | – | – | – | – | 2.77%Bought | 2.74%Cut | 2.80% | 2.78% | 2.82% |
 Narayana Hrudayalaya | – | – | – | – | – | – | – | 1.52%Bought | 1.53% | 1.59% | 2.59%Added | 2.74%Added |
 Syngene International | – | 2.78% | 2.85%Added | 2.20% | 1.86% | 1.86% | 2.09% | 1.85% | 1.77% | 1.93%Added | 2.42%Added | 2.46%Added |
Per cent of the fund's net assets at each month end, Oct 2025 to Sep 2026. Under it, the change on the fund's previous month. "After a gap" is a holding after a month with no portfolio on record, so when it was bought is not known; "Not filed" is one gone across such a gap.
Portfolio turnover, per cent of assets a year
- TurnoverPortfolio turnover. How much of the portfolio the fund bought or sold over the last year, as a share of its assets, as the fund house states it. Portfolio turnover in the glossary
Highest 16.0% in Aug 2026
Risk ratios
NAV to 27 Oct 2026
Largest falls
| Largest over | FallLargest fall. The biggest drop in NAV from a high to the low that followed, before the NAV went back above that high. Largest fall in the glossary | High on | Low on | Back at the highBack at the high. The first day the NAV closed at or above the high it had fallen from. Back at the high in the glossary |
|---|---|---|---|---|
| Since Dec 2025 | −10.06% | 31 Aug 2026 | 23 Oct 2026 | Not yet |
Risk level by month
| Months | Fund | BenchmarkBenchmark's risk level. The riskometer level of the fund's benchmark index for the same month, on the same six-step scale as the fund's own. Benchmark's risk level in the glossary |
|---|---|---|
| Jun 2026 to Aug 20263 months | Very High | Very HighBSE Healthcare TRI |
The riskometer at each month end, the fund's and its benchmark's. A month with none on record is left out.
Bandhan Healthcare Fund managers
Managers now
| Manager | Return in the manager's time. The change in the plan's NAV from the day the manager took the fund over to the latest NAV; past a year, the yearly rate that would compound to the same change. Return in the manager's time in the glossary | Benchmark over the same days. The change in the fund's benchmark index over the same days as the manager's return, worked out the same way, with the dividends of the index's companies added back. Benchmark over the same days in the glossary | Difference from the benchmark. The fund's return in the manager's time less its benchmark's over the same days, in percentage points. Difference from the benchmark in the glossary | Portfolio changed after the handover. How much of the portfolio was different three months after the manager took over: half the sum of every holding's change in weight, with each side's holdings scaled to add up to 100 so a move into cash does not count. Portfolio changed after the handover in the glossary | Portfolio changed before the handover. The same measure over the three months before the manager took over, since portfolios change anyway. Portfolio changed before the handover in the glossary | Assets the manager runs. The latest monthly size of every fund the manager runs now, added up; a fund run with others counts in full for each of its managers, and the line under it counts only the funds they run alone. Assets the manager runs in the glossary | ||
|---|---|---|---|---|---|---|---|---|
| Viraj Kulkarni(equity portion) | – | – | – | – | – | 4 | ₹8,021 Cr | |
| Brijesh Shah(Debt portion) | – | – | – | – | – | 13 | ₹50,002 Cr₹1,998 Cr alone | |
| Ritika Behera(overseas portion) | – | – | – | – | – | 6 | ₹13,512 Cr | |
| Gaurav Satra(overseas portion) | – | – | – | – | – | 5 | ₹12,509 Cr |
Returns are the direct plan's growth NAV, from the day each took over to the latest NAV, beside the benchmark over the same days.
Other funds they run
| Fund | |||||
|---|---|---|---|---|---|
| Bandhan Flexi Cap FundViraj Kulkarni | Jan 2024 | +6.74%a year | – | – | ₹7,120 Cr |
| Bandhan Liquid FundBrijesh Shah | Dec 2021 | +6.44%a year | – | – | ₹15,011 Cr |
| Bandhan Money Market FundBrijesh Shah | Jul 2021 | +6.53%a year | – | – | ₹13,581 Cr |
| Bandhan Arbitrage FundBrijesh Shah | Jun 2024 | +6.87%a year | +7.07% | −0.19 pts | ₹7,734 Cr |
| Bandhan Multi Asset Allocation FundBrijesh Shah | Jan 2024 | +13.25%a year | – | – | ₹3,676 Cr |
| Bandhan Innovation FundBrijesh Shah | Apr 2024 | +17.91%a year | +2.05% | +15.86 pts | ₹3,079 Cr |
| Bandhan Arbitrage FundRitika Behera | Oct 2023 | +7.26%a year | +7.36% | −0.11 pts | ₹7,734 Cr |
| Bandhan Multi Asset Allocation FundRitika Behera | Jan 2024 | +13.25%a year | – | – | ₹3,676 Cr |
| Bandhan Arbitrage FundGaurav Satra | Jun 2024 | +6.87%a year | +7.07% | −0.19 pts | ₹7,734 Cr |
| Bandhan Multi Asset Allocation FundGaurav Satra | Jan 2024 | +13.25%a year | – | – | ₹3,676 Cr |
The ten largest by assets, by manager. Returns are the direct plan's.
Portfolio overlap
Funds holding the most of the same securities, by weight.
Closest funds in the category
| Portfolio overlap. The share of the two funds' portfolios that is the same: for every holding they share, the smaller of its two weights, added up. Portfolio overlap in the glossary | Shared holdings. The number of securities both funds hold, cash and futures left out. Shared holdings in the glossary | |
|---|---|---|
| Nippon India Pharma FundNippon India Mutual Fund | 54.90% | 20 |
| ITI Pharma and Healthcare FundITI Mutual Fund | 54.09% | 20 |
| HDFC Pharma and Healthcare FundHDFC Mutual Fund | 50.92% | 19 |
| Aditya Birla Sun Life Pharma and Healthcare FundAditya Birla Sun Life Mutual Fund | 48.84% | 21 |
| Mirae Asset Healthcare FundMirae Asset Mutual Fund | 48.24% | 16 |
| Tata India Pharma & Healthcare FundTata Mutual Fund | 47.21% | 17 |
| UTI Healthcare FundUTI Mutual Fund | 46.58% | 22 |
| SBI Healthcare Opportunities FundSBI Mutual Fund | 44.47% | 16 |
| Baroda BNP Paribas Health and Wellness FundBaroda BNP Paribas Mutual Fund | 43.13% | 17 |
| LIC MF Healthcare FundLIC Mutual Fund | 42.74% | 12 |
Portfolios for Sep 2026. Overlap is per cent of the portfolio the two funds hold in common.
Overlap with the fund house's other funds
| Bandhan Multi-Factor FundBandhan Mutual Fund | 15.04% |
| Bandhan Large & Mid Cap FundBandhan Mutual Fund | 10.45% |
| Bandhan Midcap FundBandhan Mutual Fund | 7.17% |
| Bandhan ELSS - Tax Saver FundBandhan Mutual Fund | 7.13% |
| Bandhan Multi Cap FundBandhan Mutual Fund | 7.07% |
| Bandhan Innovation FundBandhan Mutual Fund | 6.30% |
| Bandhan Large Cap FundBandhan Mutual Fund | 5.78% |
| Bandhan Value FundBandhan Mutual Fund | 5.35% |
| Bandhan Flexi Cap FundBandhan Mutual Fund | 4.98% |
| Bandhan Business Cycle FundBandhan Mutual Fund | 3.76% |
As the fund house states it, for Sep 2026.
Changes to the fund
Newest first.
2026
- 1 AprExpenseExpense ratio stated under the new rules: a base ratio, with brokerage, levies and GST on top
Fund details
Objective
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors. Disclaimer: There is no assurance or guarantee that the scheme’s objectives will be realised.
Asset allocation
- Equity & equity related instruments engaged in Healthcare, Pharma and Allied sectors - 80%-100%, Equity & Equity related securities other than above and overseas securities - 0% - 20%
- Debt Securities and Money Market Instruments (including Government securities, Securitised debt) - 0% - 20%
- Units issued by InvITs - 0% - 10%
Type of scheme
An open-ended equity scheme investing in healthcare, pharma and allied services
- BenchmarkBenchmark. The index the fund house chose to measure the fund against, in its total return form, with dividends added back. Benchmark in the glossary
- BSE Healthcare TRI
- Risk level at launch
- Very High
- New fund offer
- 10 Nov 2025 to 24 Nov 2025
- Units first allotted
- 30 Nov 2025
- Open for sale again
- 2 Dec 2025
- Price at the offer
- ₹10 a unit
- Minimum at the offer
- ₹1,000
Plans and codes
| Plan | AMFI code | ISIN | ISIN, reinvestment | MUTF_IN | First NAV |
|---|---|---|---|---|---|
| Direct Growth | 153972 | INF194KB1KF5 | BAND_HEAL_DIR_CP4DWW | 2 Dec 2025 | |
| Regular Growth | 153974 | INF194KB1KC2 | BAND_HEAL_REG_1NAQJAE | 2 Dec 2025 | |
| Direct IDCW | 153971 | INF194KB1KG3 | INF194KB1KH1 | BAND_HEAL_DIR_19WKEN3 | 2 Dec 2025 |
| Regular IDCW | 153973 | INF194KB1KD0 | INF194KB1KE8 | BAND_HEAL_REG_1A5HH1R | 2 Dec 2025 |
This fund
- Scheme information documentThe fund's objective, terms, costs and risks in full
Factsheet
- October 2026Bandhan Mutual Fund, Sep 2026
Statement of additional information
- SAI Bandhan Mutual FundBandhan Mutual Fund, Oct 2026
Annual report
- Abridged Annual Report - Set 1 - Debt SchemesBandhan Mutual Fund, Mar 2026
- Abridged Annual Report - Set 2 - Equity SchemesBandhan Mutual Fund, Mar 2026
- Abridged Annual Report - Set 3 - Fixed Term PlansBandhan Mutual Fund, Mar 2026
- Abridged Annual Report - Set 4 - Fund of Funds SchemesBandhan Mutual Fund, Mar 2026
Riskometer disclosure
- Annual changes in Risk-o-meterBandhan Mutual Fund, Mar 2026
Portfolio overlap disclosure
- Portfolio Overlap - 30-Sep-2026Bandhan Mutual Fund, Sep 2026